Cholesterol Testing

Cholesterol Testing Market by Product Type (Test Kits, Testing Strips), Test (High-Density Lipoprotein, Low-Density Lipoprotein, Total Cholesterol Test), Test Type, Prescription Mode, End-Users - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the cholesterol testing market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[195 Pages Report] The Cholesterol Testing Market size was estimated at USD 18.97 billion in 2023 and expected to reach USD 20.72 billion in 2024, at a CAGR 9.71% to reach USD 36.31 billion by 2030.

Cholesterol Testing Market
To learn more about this report, request a free PDF copy
Cholesterol testing is a critical procedure used to estimate the levels of cholesterol and triglycerides in the blood, which indicate an individual's risk for heart disease and stroke. The purpose of cholesterol testing is to determine the balance of low-density lipoprotein (LDL), commonly known as bad cholesterol, high-density lipoprotein (HDL), often referred to as good cholesterol, and other lipid components to assess cardiovascular health. The drivers include the escalating prevalence of cardiovascular diseases, rising awareness among the population regarding the importance of early diagnosis, and the increasing geriatric population more susceptible to heart conditions. In addition, advancements in cholesterol testing methods and the convenience of point-of-care testing over traditional methods are accelerating industry expansion. However, the adoption is hampered by factors such as the cost associated with testing and the lack of awareness in some regions, which restrains the industry's potential. There is also the challenge of ensuring the accuracy and reliability of cholesterol tests, particularly as at-home testing kits become more prevalent. Nevertheless, opportunities loom in the form of rising health infrastructure investments and technological innovations, which are anticipated to introduce more user-friendly, cost-effective, and accurate testing methods, broadening the potential for cholesterol testing services across various regions.
Cholesterol Testing Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cholesterol Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cholesterol Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cholesterol Testing Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Apollo Clinics, BioReference Health, LLC, Cell Biolabs, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Merck KGaA, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SEKISUI Diagnostics, Siemens Healthineers AG, SpectraCell Laboratories, Inc., SYNLAB International GmbH, Thermo Fisher Scientific Inc., and Unilab Clinical Laboratory.

Market Segmentation & Coverage

This research report categorizes the Cholesterol Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Test Kits
    • Testing Strips
  • Test
    • High-Density Lipoprotein
    • Low-Density Lipoprotein
    • Total Cholesterol Test
  • Test Type
    • Invasive
    • Non-Invasive
  • Prescription Mode
    • Over the Counter
    • Prescription-Based
  • End-Users
    • Ambulatory Centers
    • Clinics
    • Diagnostic Centers
    • Homecare
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Cholesterol Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cholesterol Testing Market?
  3. What are the technology trends and regulatory frameworks in the Cholesterol Testing Market?
  4. What is the market share of the leading vendors in the Cholesterol Testing Market?
  5. Which modes and strategic moves are suitable for entering the Cholesterol Testing Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Cholesterol Testing Market, by Product Type
  7. Cholesterol Testing Market, by Test
  8. Cholesterol Testing Market, by Test Type
  9. Cholesterol Testing Market, by Prescription Mode
  10. Cholesterol Testing Market, by End-Users
  11. Americas Cholesterol Testing Market
  12. Asia-Pacific Cholesterol Testing Market
  13. Europe, Middle East & Africa Cholesterol Testing Market
  14. Competitive Landscape
  15. Competitive Portfolio
  16. List of Figures [Total: 26]
  17. List of Tables [Total: 464]
  18. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the Cholesterol Testing Market?
    Ans. The Global Cholesterol Testing Market size was estimated at USD 18.97 billion in 2023 and expected to reach USD 20.72 billion in 2024.
  2. What is the Cholesterol Testing Market growth?
    Ans. The Global Cholesterol Testing Market to grow USD 36.31 billion by 2030, at a CAGR of 9.71%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.